<html>
<head>PUBMED IDs for ret-II</head>
<body bgcolor='#C5F0F2'><h1>ret-II</h1><a href='https://pubmed.ncbi.nlm.nih.gov/3226727/'>Molecular cloning and characterization of human ret-II oncogene.</a> September 1  1988<br><a href='https://pubmed.ncbi.nlm.nih.gov/3143113/'>Deletion of transfected oncogenes from NIH 3T3 transformants by inhibitors of poly(ADP-ribose) polymerase.</a> December 1  1988<br><a href='https://pubmed.ncbi.nlm.nih.gov/2734021/'>Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing.</a> January Oncogene
  6<br><a href='https://pubmed.ncbi.nlm.nih.gov/2334411/'>cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line.</a> April 30  1990<br><a href='https://pubmed.ncbi.nlm.nih.gov/9443391/'>Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5.</a> January 27  1998<br></body></html>
